Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 12:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 228 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Zmax Clear all

Conditions: Intubation Complication
Interventions: Budesonide and Azithromycin, Placebo control of budesonide and azithromycin; Drug · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Preterm Premature Ruptured Membranes
Interventions: Azithromycin, Erythromycin; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Gonorrhoea
Interventions: Azithromycin, Cefixime; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Infections
Interventions: Azithromycin Pill, Placebo; Drug
Lead sponsor: Arrowhead Regional Medical Center; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Colton, California

Conditions: Gonorrhea, Neisseria Gonorrhoeae, Chlamydia Trachomatis
Interventions: Patient delivered partner therapy, Targeted public health partner services; Other · Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 14 Years and older
Enrollment: 33,222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Olympia, Washington • Seattle, Washington

Conditions: Endometritis
Interventions: Azithromycin, Cefazolin; Drug
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: COVID-19, Corona Virus Infection, Coronavirus-19, Sars-CoV2
Interventions: Hydroxychloroquine, Azithromycin, Vitamin C, Vitamin D, Zinc; Drug · Dietary Supplement
Lead sponsor: ProgenaBiome; Other
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Ventura, California

Conditions: Pediatric Asthma, Critical Illness
Interventions: Azithromycin; Drug
Lead sponsor: Johns Hopkins All Children's Hospital; Other
Eligibility: 3 Years to 17 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Child Development
Interventions: Azithromycin, Amoxicillin, Cotrimoxazole, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 6 Months to 59 Months
Enrollment: 252 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Respiratory Tract Infections, Chronic Bronchitis, Pneumonia
Interventions: Telithromycin, Azithromycin; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 35 Years
Enrollment: 2,051 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Endometritis
Interventions: Azithromycin; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Macrolide Antibiotic (Azithromycin), Placebo; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 40 Years and older
Enrollment: 1,142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 10
States / cities: Birmingham, Alabama • San Francisco, California • Torrance, California + 7 more

Conditions: Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth
Interventions: Ceftriaxone 1000 MG, Clarithromycin 500mg, Metronidazole 500 mg, Ampicillin 2 GM Injection, Amoxicillin 250 MG, Azithromycin, Erythromycin; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Columbus, Ohio • Galveston, Texas

Conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
Interventions: Liposomal Cyclosporine A, standard of care; Drug
Lead sponsor: Zambon SpA; Industry
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 25
States / cities: Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 16 more

Conditions: Preterm Premature Rupture of Membranes (PPROM)
Interventions: Azithromycin, Erythromycin, Ampicillin, Amoxicillin; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 3
States / cities: Austin, Texas • Galveston, Texas • Salt Lake City, Utah

Conditions: SARS-CoV-2, COVID-19
Interventions: Hydroxychloroquine, Azithromycin, Placebo oral tablet; Drug
Lead sponsor: Salomeh Keyhani MD; Federal
Eligibility: 216 Months and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Otitis Media, Suppurative, Otitis Media, Purulent
Interventions: Telithromycin, Azithromycin; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 6 Months to 6 Years
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Community-acquired Pneumonia
Interventions: Doxycycline, Azithromycin; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 1,120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 5
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Mankato, Minnesota + 2 more

Conditions: Respiratory Syncytial Virus, Bronchiolitis
Interventions: Oral azithromycin, Placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 1 Month to 18 Months
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Contact Lens Dry Eye
Interventions: azithromycin ophthalmic solution, 1%, Visine® for Contacts®; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Chlamydial Infection
Interventions: Azithromycin; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 12 Years to 21 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Asthma, Chronic Obstructive Pulmonary Disease
Interventions: azithromycin; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Trachoma
Interventions: Surveillance and treatment with azithromycin of newcomer and traveler families, Usual care; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: Not listed
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pharyngitis, Tonsillitis
Interventions: Azithromycin; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 6
States / cities: Rancho Cordova, California • Chicago, Illinois • Murray, Utah + 1 more

Search by objective public record fields.

Incidence of Acute Laryngeal Injury Following Endotracheal Intubation

Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes

Cefixime / Azithromycin pK Study

Azithromycin Before Induction

Washington State Community Expedited Partner Treatment (EPT) Trial

Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis

A Study of Quintuple Therapy to Treat COVID-19 Infection

Azithromycin for Critical Asthma - Pediatrics

Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso

KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections

The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery

Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)

Treatment of ppROM With Erythromycin vs. Azithromycin Trial

VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)

TELI COM - Telithromycin in Children With Otitis Media

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)

YCFM (Youth Correctional Facilities Males)

Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease

A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial

PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients